NMPA’s Review Points for Tumor Gene Variation Detection Reagents: Key Highlights and Implications July 9, 2026
NMPA Sets Classification and Naming Standards for BCI Medical Devices, with Class II Exception for Non‑AI Stroke Rehab July 6, 2026
